Clinical Trial

A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.

Name: A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy. — clinical trial record (NCT07375758)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a Phase I/II study designed to evaluate the safety, tolerability, PK and PD of subcutaneous MIL116, an anti-APRIL monoclonal antibody, in healthy participants and patients with IgA Nephropathy.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-14

Trial Details

NCT Number	NCT07375758
Lead Sponsor	Beijing Mabworks Biotech Co., Ltd.
Conditions	Immunoglobulin A Nephropathy
Enrollment	130 participants
Start Date	2026-02-05
Primary Completion	2028-06 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2026-04-13